Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity

References

• Schäfer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006;212:327–337.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255.
   PubMed Web of Science ®Google Scholar
• Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130:1785–1796.
   PubMed Web of Science ®Google Scholar
• Balato N, Balato A, Gallo L, et al. Psoriasis and osteoporosis: data from a Southern Italian population. Arch Osteoporos. 2012;7:321–323.
   PubMedGoogle Scholar
• Balato N, Napolitano M, Ayala F, et al. Nonalcoholic fatty liver disease, spleen and psoriasis: new aspects of low-grade chronic inflammation. World J Gastroenterol. 2015 14;21:6892–6897.
   PubMed Web of Science ®Google Scholar
• Sales R, Torres T. Psoriasis and metabolic syndrome. Acta Dermatovenerol Croat. 2014;22(3):169–174.
   PubMed Web of Science ®Google Scholar
• Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–835.
   PubMed Web of Science ®Google Scholar
• Mebazaa A, El Asmi M, Zidi W, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol. 2011;25:705–709.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68–73.
   PubMed Web of Science ®Google Scholar
• Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321–328.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Gilutz H, Henkin Y, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol. 2007;87:506–509.
   PubMed Web of Science ®Google Scholar
• Zindanci I, Albayrak O, Kavala M, et al. Prevalence of metabolic syndrome in patients with psoriasis. ScientificWorldJournal. 2012;2012:312–463.
   Web of Science ®Google Scholar
• Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011;147:419–424.
   PubMed Web of Science ®Google Scholar
• Quaranta M, Burden AD, Griffiths CE, et al. Differential contribution of CDKAL1 variants to psoriasis, Crohn’s disease and type II diabetes. Genes Immun. 2009;10:654–658.
   PubMed Web of Science ®Google Scholar
• Wolf N, Quaranta M, Prescott NJ, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45:114–116.
   PubMed Web of Science ®Google Scholar
• Barrea L, Macchia PE, Tarantino G, et al. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. J Transl Med. 2015 16;13:303.
   PubMed Web of Science ®Google Scholar
• Barrea L, Balato N, Di Somma C, et al. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med. 2015 27;13:18.
   PubMed Web of Science ®Google Scholar
• Guida B, Napoleone A, Trio R, et al. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial. Clin Nutr. 2014;33:399–405.
   PubMed Web of Science ®Google Scholar
• Balato A, Megna M. Adipose tissue and cutaneous inflammation. In: Gaspari A, Tyring S, Kaplan D, editors. Clinical and basic immunodermatology. Cham: Springer International Publishing; 2016.
   Google Scholar
• Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.
   PubMed Web of Science ®Google Scholar
• Zhao R, Tang D, Yi S, et al. Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes. PLoS One. 2014;9:e85770.
   PubMed Web of Science ®Google Scholar
• Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18:363–374.
   PubMed Web of Science ®Google Scholar
• Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol. 2009;129:1628–1642.
   PubMed Web of Science ®Google Scholar
• Winer S, Paltser G, Chan Y, et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39:2629–2635.
   PubMed Web of Science ®Google Scholar
• Hutcheson J. Adipokines influence the inflammatory balance in autoimmunity. Cytokine. 2015;75:272–279.
   PubMed Web of Science ®Google Scholar
• Lago F, Dieguez C, Gómez-Reino J, et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3:716–724.
   PubMedGoogle Scholar
• Fernández-Riejos P, Najib S, Santos-Alvarez J, et al. Role of leptin in the activation of immune cells. Mediators Inflamm. 2010;2010:1–8.
   Web of Science ®Google Scholar
• Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med. 2007;262:408–414.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129–139.
   PubMed Web of Science ®Google Scholar
• Richards AA, Stephens T, Charlton HK, et al. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol. 2006;20:1673–1687.
   PubMed Web of Science ®Google Scholar
• Jamaluddin MS, Weakley SM, Yao Q, et al. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol. 2012;165:622–632.
   PubMed Web of Science ®Google Scholar
• Schelbert KB. Comorbidities of obesity. Prim Care. 2009;36:271–285.
   PubMed Web of Science ®Google Scholar
• Bertrand C, Valet P, Castan-Laurell I. Apelin and energy metabolism. Front Physiol. 2015;6:115.
   PubMed Web of Science ®Google Scholar
• Schultz S, Beck-Sickinger AG. Chemerin and vaspin: possible targets to treat obesity? ChemMedChem. 2013;8:549–559.
   PubMed Web of Science ®Google Scholar
• Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, et al. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutr. 2015;6:748–762.
   PubMed Web of Science ®Google Scholar
• Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46:2347–2355.
   PubMed Web of Science ®Google Scholar
• Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509–1517.
   PubMed Web of Science ®Google Scholar
• Ford ES, Mokdad AH. Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab. 2008;93:S1–S8.
   PubMed Web of Science ®Google Scholar
• Antuna-Puente B, Feve B, Fellahi S, et al. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34:2–11.
   PubMed Web of Science ®Google Scholar
• Zúñiga LA, Shen W-J, Joyce-Shaikh B, et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010;185(11):6947–6959.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang L, Jiang Y, et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS One. 2011;6:e23737.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Lora V, Bonauguri C, et al. Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. Br J Dermatol. 2013;168:749–755.
   PubMed Web of Science ®Google Scholar
• Jin D, Sun J, Huang J, et al. TNF-α reduces g0s2 expression and stimulates lipolysis through PPAR-γ inhibition in 3T3-L1 adipocytes. Cytokine. 2014;69:196–205.
   PubMed Web of Science ®Google Scholar
• Saraceno R, Schipani C, Mazzotta A, et al. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res. 2008;57:290–295.
   PubMed Web of Science ®Google Scholar
• Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61:2238–2247.
   PubMed Web of Science ®Google Scholar
• Sterry W, Strober BE, Menter A, et al. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157:649–655.
   PubMed Web of Science ®Google Scholar
• Kintscher U, Hartge M, Hess K, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1304–1310.
   PubMed Web of Science ®Google Scholar
• Duffaut C, Galitzky J, Lafontan M, et al. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun. 2009;384:482–485.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology. 2013;145:366–374.
   PubMed Web of Science ®Google Scholar
• Cipolletta D, Kolodin D, Benoist C, et al. Tissular Tregs: a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol. 2011;23:431–437.
   PubMed Web of Science ®Google Scholar
• Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149:166–176.
   PubMed Web of Science ®Google Scholar
• Megna M, Napolitano M, Balato A, et al. Psoriasis in children: a review. Curr Pediatr Rev. 2015;11:10–26.
   PubMedGoogle Scholar
• Kanemaru K, Matsuyuki A, Nakamura Y, et al. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice. Exp Dermatol. 2015;24:436–442.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr. 2008;88:1242–1247.
   PubMed Web of Science ®Google Scholar
• Di Minno MND, Peluso R, Iervolino S, et al. Obesity and the prediction of minimal disease activity. A prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken). 2013;65:141–147.
   PubMed Web of Science ®Google Scholar
• Bardazzi F, Balestri R, Baldi E, et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther. 2010;23:S14–S19.
   Web of Science ®Google Scholar
• Takahashi H, Tsuji H, Takahashi I, et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol. 2008;159(5):1207–1208.
   PubMed Web of Science ®Google Scholar
• Baran A, Flisiak I, Jaroszewicz J, et al. Effect of psoriasis activity on serum adiponectin and leptin levels. Postep Derm Alergol. 2015;32(2):101–106.
   PubMed Web of Science ®Google Scholar
• Huang H, Shen E, Tang S, et al. Increased serum resistin levels correlate with psoriasis: a meta-analysis. Lipids Health Dis. 2015;14:44.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Tsuji H, Ishida-Yamamoto A, et al. Serum level of adiponectin increases and those of leptin and resistin decrease following the treatment of psoriasis. J Dermatol. 2013;40(6):475–476.
   PubMed Web of Science ®Google Scholar
• Coban M, Tasli L, Turgut S, et al. Association of adipokines, insulin resistance, hypertension and dyslipidemia in patients with psoriasis vulgaris. Ann Dermatol. 2016;28(1):74–79.
   PubMed Web of Science ®Google Scholar
• Mariani F, Roncucci L. Chemerin/chemR23 axis in inflammation onset and resolution. Inflamm Res. 2015;64:85–95.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Russell CB, Martin DA, et al. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013;34:174–181.
   PubMed Web of Science ®Google Scholar
• Chiricozzi A. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis. Actas Dermosifiliogr. 2014;105:9–20.
   PubMedGoogle Scholar
• Rizzo HL, Kagami S, Phillips KG, et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J Immunol. 2011;186:1495–1502.
   PubMed Web of Science ®Google Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010;17:332–341.
   PubMed Web of Science ®Google Scholar
• Wernstedt I, Edgley A, Berndtsson A, et al. Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2006;291:R551–7.
   PubMed Web of Science ®Google Scholar
• Dou L, Zhao T, Wang L, et al. miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. J Biol Chem. 2013;288:22596–22606.
   PubMed Web of Science ®Google Scholar
• Cerman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol. 2008;159:820–826.
   PubMed Web of Science ®Google Scholar
• Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159:342–350.
   PubMed Web of Science ®Google Scholar
• Xue K, Liu H, Jian Q, et al. Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro-a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol. 2013;22:406–410.
   PubMed Web of Science ®Google Scholar
• Okan G, Baki AM, Yorulmaz E, et al. Serum visfatin, fetuin-A, and pentraxin 3 levels in patients with psoriasis and their relation to disease severity. J Clin Lab Anal. 2015. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Skrzeczyńska-Moncznik J, Wawro K, Stefańska A, et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem Biophys Res Commun. 2009;380:323–327.
   PubMed Web of Science ®Google Scholar
• Kaur S, Zilmer K, Kairane C, et al. Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis. Br J Dermatol. 2008;159:1364–1367.
   PubMed Web of Science ®Google Scholar
• Shibata S, Saeki H, Tada Y, et al. Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci. 2009;55:62–63.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Honma M, Ishida-Yamamoto A, et al. Adiponectin and leptin modulate cell proliferation and cytokine secretion of normal human keratinocytes and T lymphocytes. J Dermatol Sci. 2010;59:143–145.
   PubMed Web of Science ®Google Scholar
• Dalmas E, Venteclef N, Caer C, et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63:1966–1977.
   PubMed Web of Science ®Google Scholar
• Chawla A, Nguyen KD, Goh YPS. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11:738–749.
   PubMed Web of Science ®Google Scholar
• Grohmann M, Sabin M, Holly J, et al. Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-I. J Lipid Res. 2005;46:93–103.
   PubMed Web of Science ®Google Scholar
• Owczarczyk-Saczonek A, Placek W, Rybak-d’Obyrn J, et al. Influence of ustekinumab on body weight of patients with psoriasis: an initial report. Postepy Dermatol Alergol. 2014;31:29–31.
   PubMed Web of Science ®Google Scholar
• Tan E, Baker C, Foley P. Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis. Australas J Dermatol. 2013;54:259–263.
   PubMed Web of Science ®Google Scholar
• Renzo LDI, Saraceno R, Schipani C, et al. Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Dermatol Ther. 2011;24:446–451.
   PubMed Web of Science ®Google Scholar
• Peluso I, Palmery M. The relationship between body weight and inflammation: Lesson from anti-TNF-α antibody therapy. Hum Immunol. 2016;77:47–53.
   PubMed Web of Science ®Google Scholar
• Pina T, Genre F, Lopez-Mejias R, et al. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy. J Eur Acad Dermatol Venereol. 2015;29:1995–2001.
   PubMed Web of Science ®Google Scholar
• Vasilopoulos Y, Sourli F, Zafiriou E, et al. High serum levels of HIF-1α in psoriatic patients correlate with an over-expression of IL-6. Cytokine. 2013;62:38–39.
   PubMed Web of Science ®Google Scholar
• Tangvarasittichai S, Pongthaisong S, Tangvarasittichai O. Tumor necrosis factor-Α, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J Clin Biochem. 2016;31:68–74.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian J, Tian X, et al. Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PLoS One. 2014;9:e92450.
   PubMed Web of Science ®Google Scholar
• Küçük M, Altınkaya SÖ, Nergiz S, et al. Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2014;30:423–427.
   PubMed Web of Science ®Google Scholar
• Matthews VB, Allen TL, Risis S, et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia. 2010;53:2431–2441.
   PubMed Web of Science ®Google Scholar
• Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:71.
   PubMedGoogle Scholar
• Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23:770–784.
   PubMed Web of Science ®Google Scholar
• Tadokoro S, Ide S, Tokuyama R, et al. Leptin promotes wound healing in the skin. PLoS One. 2015;10:e0121242.
   PubMed Web of Science ®Google Scholar
• Savini I, Catani MV, Rossi A, et al. Vitamin C recycling is enhanced in the adaptive response to leptin-induced oxidative stress in keratinocytes. Endocrinology. 2008;149:5189–5198.
   PubMed Web of Science ®Google Scholar
• Moehlecke M, Canani LH, Silva LOJE, et al. Determinants of body weight regulation in humans. Arch Endocrinol Metab. 2016;60:152–162.
   PubMed Web of Science ®Google Scholar
• Versini M, Jeandel P-Y, Rosenthal E, et al. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13:981–1000.
   PubMed Web of Science ®Google Scholar
• Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197–207.
   PubMed Web of Science ®Google Scholar
• Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33:35–45.
   PubMed Web of Science ®Google Scholar
• Lam QLK, Liu S, Cao X, et al. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol. 2006;36:3118–3130.
   PubMed Web of Science ®Google Scholar
• Balato A, Di Caprio R, Lembo S, et al. Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm. 2014;12:341–350.
   Web of Science ®Google Scholar
• Orlova EG, Shirshev SV. Role of leptin and ghrelin in induction of differentiation of IL-17-producing and T-regulatory cells. Bull Exp Biol Med. 2014;156:819–822.
   PubMed Web of Science ®Google Scholar
• Noh M. Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells. Biochem Pharmacol. 2012;83:661–670.
   PubMed Web of Science ®Google Scholar
• Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178:1748–1758.
   PubMed Web of Science ®Google Scholar
• Curat CA, Wegner V, Sengenès C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49:744–747.
   PubMed Web of Science ®Google Scholar
• Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul. 2010;44:25–36.
   PubMedGoogle Scholar
• Kanda N, Hau CS, Tada Y, et al. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology. 2011;152:3155–3164.
   PubMed Web of Science ®Google Scholar
• Hau CS, Kanda N, Noda S, et al. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Am J Pathol. 2013;182:1705–1717.
   PubMed Web of Science ®Google Scholar
• Zabel BA, Kwitniewski M, Banas M, et al. Chemerin regulation and role in host defense. Am J Clin Exp Immunol. 2014;3:1–19.
   PubMedGoogle Scholar
• Albanesi C, Scarponi C, Pallotta S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med. 2009;206:249–258.
   PubMed Web of Science ®Google Scholar
• Banas M, Zabieglo K, Kasetty G, et al. Chemerin is an antimicrobial agent in human epidermis. PLoS One. 2013;8:e58709.
   PubMed Web of Science ®Google Scholar
• Luangsay S, Wittamer V, Bondue B, et al. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol. 2009;183:6489–6499.
   PubMed Web of Science ®Google Scholar
• Kulig P, Kantyka T, Zabel BA, et al. Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol. 2011;187:1403–1410.
   PubMed Web of Science ®Google Scholar
• Kulig P, Zabel BA, Dubin G, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol. 2007;178:3713–3720.
   PubMed Web of Science ®Google Scholar
• Davenport AP, Alexander SP, Sharman JL, et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev. 2013;65:967–986.
   PubMed Web of Science ®Google Scholar
• Banas M, Zegar A, Kwitniewski M, et al. The expression and regulation of chemerin in the epidermis. PLoS One. 2015;10:e0117830.
   PubMed Web of Science ®Google Scholar
• Parlee SD, Ernst MC, Muruganandan S, et al. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. Endocrinology. 2010;151:2590–2592.
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE Adiponectin, the past two decades. J Mol Cell Biol. 2016;8:93–100.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Pak YK, Jang P-G, et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci. 2006;9:901–906.
   PubMed Web of Science ®Google Scholar
• Tong K-M, Chen C-P, Huang K-C, et al. Adiponectin increases MMP-3 expression in human chondrocytes through AdipoR1 signaling pathway. J Cell Biochem. 2011;112:1431–1440.
   PubMed Web of Science ®Google Scholar
• Lago R, Gomez R, Otero M, et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage. 2008;16:1101–1109.
   PubMed Web of Science ®Google Scholar
• Gomez R, Scotece M, Conde J, et al. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann Rheum Dis. 2011;70:2052–2054.
   PubMed Web of Science ®Google Scholar
• Neumeier M, Weigert J, Schäffler A, et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol. 2006;79:803–808.
   PubMed Web of Science ®Google Scholar
• Jung MY, Kim H-S, Hong H-J, et al. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. J Immunol. 2012;188:2592–2601.
   PubMed Web of Science ®Google Scholar
• Molinelli E, Campanati A, Ganzetti G, et al. Biologic therapy in immune mediated inflammatory disease: basic science and clinical concepts. Curr Drug Saf. 2016;11:35–43.
   PubMed Web of Science ®Google Scholar
• Danilenko DM. Review paper: preclinical models of psoriasis. Vet Pathol. 2008;45:563–575.
   PubMed Web of Science ®Google Scholar
• Campanati A, Ganzetti G, Giuliodori K, et al. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis. Int J Dermatol. 2015;54:839–845.
   PubMed Web of Science ®Google Scholar